EUCTR2004-002218-13-IT进行中（未招募）不适用
A phase III, multicenter, randomized, open, comparative study to evaluate if the addition of r-hLH (Luveris) ti FSH from day 8 of ovarian stimulation is able to decrease total FSH dose and to improve cycle outcome in infertile women undergoing ART, who required high FSH dose in a previous cycle.
INDUSTRIA FARMACEUTICA SERONO0 个研究点目标入组 250 人开始时间: 2005年9月20日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Study to compare the reactogenicity and evaluate the safety and immunogenicity of GSK Biologicals combined hepatitis A / hepatitis B vaccine administered according to a 0, 6 month schedule versus Twinrix™ Junior administered according to a 0, 1, 6 month schedule in healthy children between 1 to 11 years old.Vaccination of healthy children from 1 to 11 years old against HepatitisEUCTR2015-001515-12-Outside-EU/EEAGlaxoSmithKline Biologicals511
进行中（未招募）
不适用
A study for evaluation of immunogenicity and reactogenicity of Fluarix/Influsplit SSW 2012/2013 in people aged 18 years and above.EUCTR2012-000789-39-DEGlaxoSmithKline Biologicals
进行中（未招募）
3 期
Study to assess the efficacy and safety of alpelisib in combination with olaparib in participants with platinum-resistant or refractory gBRCAnm HGSOCOvarian CancerJPRN-jRCT2031210106Suzuki Kazuyuki30
已完成
3 期
A study of Alcaftadine 0.25% w/v and Ketorolac Tromethamine 0.4% w/v Eye Drops for the treatment of Subjects with Ocular Itching associated with Allergic ConjunctivitisCTRI/2018/09/015810Ajanta Pharma Ltd222
已完成
3 期
A Clinical study to check the effect and safety of Olopatadine Hydrochloride Ophthalmic Solution 0.7% w/v compared with Olopatadine Hydrochloride Ophthalmic Solution 0.2% w/v in patients suffering with ocular itching associated with allergic conjunctivitis.CTRI/2018/05/013693Ajanta Pharma Ltd219